{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:04:43Z","timestamp":1759601083136},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,23]]},"DOI":"10.18632\/oncotarget.24743","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T10:43:57Z","timestamp":1521801837000},"page":"16134-16148","source":"Crossref","is-referenced-by-count":7,"title":["Regulation of breast cancer induced bone disease by cancer-specific IKK\u03b2"],"prefix":"10.18632","volume":"9","author":[{"given":"Silvia","family":"Marino","sequence":"first","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"},{"name":"Bone and Cancer Group, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Capulli","sequence":"additional","affiliation":[{"name":"University of L\u2019Aquila, Department of Biotechnological and Applied Clinical Sciences, L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Sophocleous","sequence":"additional","affiliation":[{"name":"Rheumatology and Bone Disease Unit, Centre for Genomic and Experimental Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Logan","sequence":"additional","affiliation":[{"name":"Bone and Cancer Group, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK"},{"name":"Rheumatology and Bone Disease Unit, Centre for Genomic and Experimental Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Mollat","sequence":"additional","affiliation":[{"name":"Galapagos SASU, Romainville, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mognetti","sequence":"additional","affiliation":[{"name":"University of Turin, Department of Clinical and Biological Sciences, Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ventura","sequence":"additional","affiliation":[{"name":"Department of Pathology, San Salvatore Hospital, L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Sims","sequence":"additional","affiliation":[{"name":"Applied Bioinformatics of Cancer, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Rucci","sequence":"additional","affiliation":[{"name":"University of L\u2019Aquila, Department of Biotechnological and Applied Clinical Sciences, L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart H.","family":"Ralston","sequence":"additional","affiliation":[{"name":"Rheumatology and Bone Disease Unit, Centre for Genomic and Experimental Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK"},{"name":"Bone and Cancer Group, Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","article-title":"Crosstalk between cancer cells and bone microenvironment in bone metastasis","volume":"328","author":"Hiraga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2013.07.036","article-title":"Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma","volume":"154","author":"Massagu\u00e9","year":"2013","journal-title":"Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cr.2008.30","article-title":"The IkappaB kinase-a bridge between inflammation and cancer","volume":"18","author":"Karin","year":"2008","journal-title":"Cell Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"Karin","year":"2005","journal-title":"J Exp Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1096\/fj.10-164095","article-title":"Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formationand prevent ovariectomy-induced bone loss","volume":"24","author":"Ralston","year":"2010","journal-title":"FASEB J"},{"key":"9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4","article-title":"IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis","volume":"25","author":"Abu-Amer","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.1954","article-title":"Inhibition of osteoblastic bone formation by nuclear factor-kappaB","volume":"15","author":"Wang","year":"2009","journal-title":"Nat Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1210\/en.2010-0399","article-title":"Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice","volume":"151","author":"Ohya","year":"2010","journal-title":"Endocrinology"},{"key":"13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/187569211796957584","article-title":"Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines","volume":"9","author":"Nahta","year":"2011","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"e18447","DOI":"10.1371\/journal.pone.0018447","article-title":"regulates the repair of DNA double-strand breaks induced by ionizing radiation in MCF-7 breast cancer cells","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cellsig.2012.01.012","article-title":"IKK-\u03b2 mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death","volume":"24","author":"Basaga","year":"2012","journal-title":"Cell Signal"},{"key":"16","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1038\/srep04057","article-title":"Nuclear factor-\u0138B plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells","volume":"4","author":"Tanaka","year":"2014","journal-title":"Sci Rep"},{"key":"17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","article-title":"IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway","volume":"130","author":"Lai","year":"2007","journal-title":"Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-10-53","article-title":"I\u03baB kinases increase Myc protein stability and enhance progression of breast cancer cells","volume":"10","author":"Cheng","year":"2011","journal-title":"Mol Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1038\/onc.2011.28","article-title":"Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-\u03baB: implication in breast cancer metastasis","volume":"30","author":"Lim","year":"2011","journal-title":"Oncogene"},{"key":"20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/0008-5472.CAN-07-3094","article-title":"Altered TAB1: I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression","volume":"68","author":"Schiemann","year":"2008","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","article-title":"IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a","volume":"117","author":"Hung","year":"2004","journal-title":"Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cellsand prevent osteolytic bone metastasis","volume":"8","author":"Ralston","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-009-0344-y","article-title":"Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue","volume":"119","author":"White","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Massagu\u00e9","year":"2003","journal-title":"Cancer Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/cr.2012.89","article-title":"Global secretome analysis identifies novel mediators of bone metastasis","volume":"22","author":"Kang","year":"2012","journal-title":"Cell Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jbmr.1951","article-title":"Proline\/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss","volume":"28","author":"Teti","year":"2013","journal-title":"J Bone Miner Res"},{"key":"27","first-page":"621","article-title":"Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases","volume":"25","author":"Chirgwin","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer","volume":"107","author":"Gaynor","year":"2001","journal-title":"J Clin Invest"},{"key":"29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Werb","year":"2002","journal-title":"Nature"},{"key":"30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.coph.2009.06.007","article-title":"Inflammation, cancer, and bone loss","volume":"9","author":"Abu-Amer","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.18632\/oncotarget.2739","article-title":"Targeting of TGF-\u03b2-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer","volume":"6","author":"Hou","year":"2015","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bjc.2015.267","article-title":"MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics","volume":"113","author":"Perrot-Applanat","year":"2015","journal-title":"Br J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1015872531675","article-title":"Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells","volume":"73","author":"Seo","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"34","first-page":"2755","article-title":"PTHrP regulates angiogenesis and bone resorption via VEGF expression","volume":"30","author":"Sasaki","year":"2010","journal-title":"Anticancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI82585","article-title":"Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair","volume":"126","author":"Olsen","year":"2016","journal-title":"J Clin Invest"},{"key":"36","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1210\/endo.141.5.7458","article-title":"Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation","volume":"141","author":"L\u00f6wik","year":"2000","journal-title":"Endocrinology"},{"key":"37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/cr.2008.273","article-title":"The IKK-related kinases: from innate immunity to oncogenesis","volume":"18","author":"Servant","year":"2008","journal-title":"Cell Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"ra119","DOI":"10.1126\/scisignal.2005533","article-title":"HSP70 mediates degradation of the p65 subunit of nuclear factor \u03baB to inhibit inflammatory signaling","volume":"7","author":"Kaisho","year":"2014","journal-title":"Sci Signal"},{"key":"39","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.15252\/embj.201488183","article-title":"I\u03ba\u0392\u03b1 inhibits apoptosis at the outer mitochondrial membrane independently of NF-\u03baB retention","volume":"33","author":"Grimm","year":"2014","journal-title":"EMBO J"},{"key":"40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cell.2012.12.021","article-title":"Inactivation of BAD by IKK inhibits TNF\u03b1-induced apoptosis independently of NF-\u03baB activation","volume":"152","author":"Lin","year":"2013","journal-title":"Cell"},{"key":"41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molcel.2015.07.032","article-title":"NF-\u03baB-Independent Role of IKK\u03b1\/IKK\u03b2 in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling","volume":"60","author":"Bertrand","year":"2015","journal-title":"Mol Cell"},{"key":"42","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1371\/journal.pone.0012293","article-title":"Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer","volume":"5","author":"Khoo","year":"2010","journal-title":"PLoS One"},{"key":"43","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/onc.2011.368","article-title":"FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer","volume":"31","author":"Lam","year":"2012","journal-title":"Oncogene"},{"key":"44","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/MCB.00077-09","article-title":"FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases","volume":"29","author":"Toker","year":"2009","journal-title":"Mol Cell Biol"},{"key":"45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncb1676","article-title":"ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation","volume":"10","author":"Lee","year":"2008","journal-title":"Nat Cell Biol"},{"key":"46","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/bcr1872","article-title":"Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis","volume":"10","author":"Hu","year":"2008","journal-title":"Breast Cancer Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"e1058","DOI":"10.1371\/journal.pone.0001058","article-title":"Akt1 in osteoblasts and osteoclasts controls bone remodeling","volume":"2","author":"Hay","year":"2007","journal-title":"PLoS One"},{"key":"48","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1158\/0008-5472.CAN-10-0732","article-title":"The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion","volume":"70","author":"Lisanti","year":"2010","journal-title":"Cancer Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1025905008934","article-title":"NF-kappaB in mammary gland development and breast cancer","volume":"8","author":"Karin","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"50","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1073\/pnas.0706728104","article-title":"IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2\/Her2-transformed mammary tumor-initiating cells","volume":"104","author":"Karin","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"51","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1349-7006.2009.01228.x","article-title":"Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines","volume":"100","author":"Inoue","year":"2009","journal-title":"Cancer Sci"},{"key":"52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","article-title":"Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation","volume":"82","author":"Ralston","year":"2008","journal-title":"Calcif Tissue Int"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T19:08:52Z","timestamp":1693595332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":52,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,3,23]]}},"alternative-id":["24743","29662632"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24743","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]}}}